Dyslipidemia and cardiovascular disease risk among the MASHAD study population

被引:192
作者
Hedayatnia, Mahshad [1 ]
Asadi, Zahra [1 ,2 ]
Zare-Feyzabadi, Reza [3 ]
Yaghooti-Khorasani, Mahdiyeh [3 ]
Ghazizadeh, Hamideh [2 ,3 ,4 ]
Ghaffarian-Zirak, Roshanak [3 ]
Nosrati-Tirkani, Abolfazl [3 ]
Mohammadi-Bajgiran, Maryam [3 ]
Rohban, Mohadese [3 ]
Sadabadi, Fatemeh [3 ]
Rahimi, Hamid-Reza [3 ]
Ghalandari, Marzieh [3 ]
Ghaffari, Mohammad-Seddigh [5 ]
Yousefi, Asa [5 ]
Pouresmaeili, Elnaz [5 ]
Besharatlou, Mohammad-Reza [5 ]
Moohebati, Mohsen [6 ]
Ferns, Gordon A. [7 ]
Esmaily, Habibollah [8 ]
Ghayour-Mobarhan, Majid [3 ,4 ]
机构
[1] Mashhad Univ Med Sci, Fac Med, Dept Nutr, Mashhad, Razavi Khorasan, Iran
[2] Mashhad Univ Med Sci, Student Res Comm, Mashhad, Razavi Khorasan, Iran
[3] Mashhad Univ Med Sci, Metab Syndrome Res Ctr, Sch Med, Mashhad, Razavi Khorasan, Iran
[4] Mashhad Univ Med Sci, Int UNESCO Ctr Hlth Related Basic Sci & Human Nut, Sch Med, Dept Nutr, Mashhad, Razavi Khorasan, Iran
[5] Mashhad Univ Med Sci, Fac Med, Mashhad, Razavi Khorasan, Iran
[6] Mashhad Univ Med Sci, Cardiovasc Res Ctr, Sch Med, Mashhad, Razavi Khorasan, Iran
[7] Brighton & Sussex Med Sch, Div Med Educ, Brighton, E Sussex, England
[8] Mashhad Univ Med Sci, Social Determinants Hlth Res Ctr, Mashhad, Razavi Khorasan, Iran
关键词
Dyslipidemia; Cardiovascular disease; Stable angina; Unstable angina; Myocardial infarction; Total cholesterol; DENSITY-LIPOPROTEIN CHOLESTEROL; TRIGLYCERIDE-RICH LIPOPROTEINS; CORONARY-HEART-DISEASE; HEALTHY EATING INDEX; APOLIPOPROTEIN-A-I; LIPID PARAMETERS; HDL CHOLESTEROL; EFFLUX CAPACITY; ASSOCIATION; PREVALENCE;
D O I
10.1186/s12944-020-01204-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction Dyslipidemia may be defined as increased levels of serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), or a decreased serum high-density lipoprotein cholesterol (HDL-C) concentration. Dyslipidemia is an established risk factor for cardiovascular disease (CVD). We aimed to investigate the association of dyslipidemia and CVD events among a population sample from Mashhad, in northeastern Iran. Material and methods This prospective cohort study comprised a population of 8698 men and women aged 35-65 years who were recruited from the Mashhad Stroke and Heart Atherosclerotic Disorder (MASHAD) study. Socioeconomic and demographic status, anthropometric parameters, laboratory evaluations, lifestyle factors, and medical history were gathered through a comprehensive questionnaire and laboratory and clinical assessment for all participants. Cox regression model and 95% confidence interval (CI) were used to evaluate the association of dyslipidemia and its components with CVD incidence. Results After 6 years of follow-up, 233 cases of CVD (including 119 cases of unstable angina [US], 74 cases of stable angina [SA], and 40 cases of myocardial infarction [MI]) were identified in the study population. Unadjusted baseline serum LDL-C, TC, and TG levels were positively associated with the risk of total CVD events among the entire population (HR: 1.54, 95% CI: 1.19-2; P-value< 0.01; HR: 1.53; 95% CI: 1.18-1.98; P < 0.01; HR: 1.57; 95% CI: 1.27-2.03; P < 0.01, respectively). However, after adjusting for confounding factors (age, body mass index [BMI], family history of CVD, smoking status [non-smoker, ex-smoker and current smoker], lipid lowering drug treatment, anti-hypertensive drug treatment, hypertension, healthy eating index [HEI], total energy intake, and presence of diabetes mellitus), a significant direct association only remained between TC and MI risk in men (HR: 2.71; 95%CI: 1.12-6.57; P-value< 0.05). Conclusion In the present study, TC baseline level was significantly associated with the risk of MI among men.
引用
收藏
页数:11
相关论文
共 50 条
[21]   Helicobacter Pylori Infection and Risk of Death From Cardiovascular Disease Among the Japanese Population: a Nested Case-Control Study within the JACC Study [J].
Lin, Yingsong ;
Obata, Yuki ;
Kikuchi, Shogo ;
Tamakoshi, Akiko ;
Iso, Hiroyuki .
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2015, 22 (11) :1207-1213
[22]   Second-line treatments for dyslipidemia in patients at risk of cardiovascular disease [J].
Kondo, Yoshinobu ;
Hamai, Junko ;
Nezu, Uru ;
Shigematsu, Erina ;
Kamiko, Kazunari ;
Yamazaki, Shunsuke ;
Yoshii, Taishi ;
Takahashi, Mayumi ;
Takano, Tatsuro ;
Kawasaki, Satsuki ;
Yamada, Masayo ;
Yamakawa, Tadashi ;
Terauchi, Yasuo .
ENDOCRINE JOURNAL, 2014, 61 (04) :343-351
[23]   Knowledge of modifiable risk factors for cardiovascular disease among women and the associated factors: a population-based study [J].
Bonotto, Gabriel Missaggia ;
Mendoza-Sassi, Raul Andres ;
Odeh Susin, Lulie Rosane .
CIENCIA & SAUDE COLETIVA, 2016, 21 (01) :293-302
[24]   Risk reductions for cardiovascular disease with pravastatin treatment by dyslipidemia phenotype: A post hoc analysis of the MEGA Study [J].
Nishiwaki, Masato ;
Ikewaki, Katsunori ;
Ayaori, Makoto ;
Mizuno, Kyoichi ;
Ohashi, Yasuo ;
Ohsuzu, Fumitaka ;
Ishikawa, Toshitsugu ;
Nakamura, Haruo .
JOURNAL OF CARDIOLOGY, 2013, 61 (3-4) :196-200
[25]   Temporal Trends in the Population Attributable Risk for Cardiovascular Disease The Atherosclerosis Risk in Communities Study [J].
Cheng, Susan ;
Claggett, Brian ;
Correia, Andrew W. ;
Shah, Amil M. ;
Gupta, Deepak K. ;
Skali, Hicham ;
Ni, Hanyu ;
Rosamond, Wayne D. ;
Heiss, Gerardo ;
Folsom, Aaron R. ;
Coresh, Josef ;
Solomon, Scott D. .
CIRCULATION, 2014, 130 (10) :820-828
[26]   Dyslipidemia, malnutrition, inflammation, cardiovascular disease and mortality in chronic kidney disease [J].
Peev, Vasil ;
Nayer, Ali ;
Contreras, Gabriel .
CURRENT OPINION IN LIPIDOLOGY, 2014, 25 (01) :54-60
[27]   Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis [J].
Lee, Meng ;
Saver, Jeffrey L. ;
Towfighi, Amytis ;
Chow, Jessica ;
Ovbiagele, Bruce .
ATHEROSCLEROSIS, 2011, 217 (02) :492-498
[28]   Control of Risk Factors for Cardiovascular Disease among Multinational Patient Population in the Arabian Gulf [J].
Al-Zakwani, Ibrahim ;
Al-Mahmeed, Wael ;
Arafah, Mohamed ;
Al-Hinai, Ali T. ;
Shehab, Abdullah ;
Al-Tamimi, Omer ;
Al-Awadhi, Mahmoud ;
Al-Herz, Shorook ;
Al-Anazi, Faisal ;
Al-Nemer, Khalid ;
Metwally, Othman ;
Al-Khadra, Akram ;
Fakhry, Mohammed ;
Elghetany, Hossam ;
Medani, Abdel R. ;
Yusufali, Afzal H. ;
Al-Jassim, Obaid ;
Al-Hallaq, Omar ;
Baslaib, Fahad O. A. S. ;
Amin, Haitham ;
Santos, Raul D. ;
Al-Waili, Khalid ;
Al-Hashmi, Khamis ;
Al-Rasadi, Khalid .
CURRENT VASCULAR PHARMACOLOGY, 2016, 14 (04) :374-381
[29]   Pre-Existing Depression among Newly Diagnosed Dyslipidemia Patients and Cardiovascular Disease Risk [J].
Kim, Jihoon Andrew ;
Choi, Seulggie ;
Choi, Daein ;
Park, Sang Min .
DIABETES & METABOLISM JOURNAL, 2020, 44 (02) :307-+
[30]   Cardiovascular Disease and Dyslipidemia: Beyond LDL [J].
Poess, Janine ;
Custodis, Florian ;
Werner, Christian ;
Weingaertner, Oliver ;
Boehm, Michael ;
Laufs, Ulrich .
CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (09) :861-870